These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32321717)

  • 1. Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer.
    Galletti G; Zhang C; Gjyrezi A; Cleveland K; Zhang J; Powell S; Thakkar PV; Betel D; Shah MA; Giannakakou P
    Clin Cancer Res; 2020 Jul; 26(14):3771-3783. PubMed ID: 32321717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.
    Tan MH; De S; Bebek G; Orloff MS; Wesolowski R; Downs-Kelly E; Budd GT; Stark GR; Eng C
    Breast Cancer Res Treat; 2012 Feb; 131(3):849-58. PubMed ID: 21479552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S.
    Di Bartolomeo M; Raimondi A; Cecchi F; Catenacci DVT; Schwartz S; Sellappan S; Tian Y; Miceli R; Pellegrinelli A; Giommoni E; Aitini E; Spada F; Rosati G; Marchet A; Pucci F; Zaniboni A; Tamberi S; Pressiani T; Sanna G; Cantore M; Mosconi S; Bolzoni P; Pinto C; Landi L; Soto Parra HJ; Cavanna L; Corallo S; Martinetti A; Hembrough TA; Pietrantonio F
    Tumori; 2021 Apr; 107(2):150-159. PubMed ID: 32522106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.
    Gjyrezi A; Xie F; Voznesensky O; Khanna P; Calagua C; Bai Y; Kung J; Wu J; Corey E; Montgomery B; Mace S; Gianolio DA; Bubley GJ; Balk SP; Giannakakou P; Bhatt RS
    J Clin Invest; 2020 Jun; 130(6):3287-3298. PubMed ID: 32478682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.
    Li X; Yao R; Yue L; Qiu W; Qi W; Liu S; Yao Y; Liang J
    J Cell Mol Med; 2014 May; 18(5):811-23. PubMed ID: 24628949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer Cells.
    Souchek JJ; Davis AL; Hill TK; Holmes MB; Qi B; Singh PK; Kridel SJ; Mohs AM
    Mol Cancer Ther; 2017 Sep; 16(9):1819-1830. PubMed ID: 28615298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement.
    Thakkar PV; Kita K; Castillo UD; Galletti G; Madhukar N; Navarro EV; Barasoain I; Goodson HV; Sackett D; Díaz JF; Lu Y; RoyChoudhury A; Molina H; Elemento O; Shah MA; Giannakakou P
    Dev Cell; 2021 Dec; 56(23):3264-3275.e7. PubMed ID: 34672971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer.
    Zheng WE; Chen H; Yuan SF; Wu LL; Zhang W; Sun HY; Chen WJ
    J BUON; 2012; 17(2):284-90. PubMed ID: 22740207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
    Martin SK; Kyprianou N
    Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
    Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
    PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel and docetaxel in prostate cancer.
    Obasaju C; Hudes GR
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):525-45. PubMed ID: 11525295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers.
    Wang R; Wang H; Wang Z
    J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
    Tan IB; Ivanova T; Lim KH; Ong CW; Deng N; Lee J; Tan SH; Wu J; Lee MH; Ooi CH; Rha SY; Wong WK; Boussioutas A; Yeoh KG; So J; Yong WP; Tsuburaya A; Grabsch H; Toh HC; Rozen S; Cheong JH; Noh SH; Wan WK; Ajani JA; Lee JS; Tellez MS; Tan P
    Gastroenterology; 2011 Aug; 141(2):476-85, 485.e1-11. PubMed ID: 21684283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel.
    Li X; Qiu W; Liu B; Yao R; Liu S; Yao Y; Liang J
    J Transl Med; 2013 Sep; 11():204. PubMed ID: 24004449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer.
    Hwang JE; Hong JY; Kim K; Kim SH; Choi WY; Kim MJ; Jung SH; Shim HJ; Bae WK; Hwang EC; Lee KH; Lee JH; Cho SH; Chung IJ
    BMC Cancer; 2013 Sep; 13():431. PubMed ID: 24053422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA signature associated with outcome of gastric cancer patients following chemotherapy.
    Kim CH; Kim HK; Rettig RL; Kim J; Lee ET; Aprelikova O; Choi IJ; Munroe DJ; Green JE
    BMC Med Genomics; 2011 Nov; 4():79. PubMed ID: 22112324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective-multicenter study.
    Gunaldi M; Kose F; Serkan Demirci N; Gunduz S; Ozdemir N; Kocoglu H; Okuturlar Y; Murat Sedef A; Erdem D; Sezgin Goksu S; Umut Erdem G; Yildirim M
    J BUON; 2018; 23(2):416-421. PubMed ID: 29745086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
    Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
    BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.